PSP001 - A First-in-class human PEGIFN-λ Chimera

Q1 2020, FDA IND Submission
Date:2019-08-05 18:47:50 | Visits:


 
 Prev:Q3 2020, Phase I Clinical Trial
 Next:Status:Q4 2019, FDA Pre-IND Meeting